(19)
(11) EP 1 044 187 A1

(12)

(43) Date of publication:
18.10.2000 Bulletin 2000/42

(21) Application number: 98959050.0

(22) Date of filing: 11.12.1998
(51) International Patent Classification (IPC)7C07D 213/56, A61K 31/44, C07D 215/14, C07D 237/08, C07D 239/26, C07D 241/12, A61K 31/50, A61K 31/505, A61K 31/495
(86) International application number:
PCT/GB9803/712
(87) International publication number:
WO 9931/065 (24.06.1999 Gazette 1999/25)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 12.12.1997 US 989353
07.12.1998 US 206245

(71) Applicants:
  • Cell Pathways, Inc.
    Horsham,Pennsylvania 19044 (US)
  • THE UNIVERSITY OF ARIZONA
    Tucson,Arizona 85721 (US)

(72) Inventors:
  • SPERL, Gerhard
    North Wales, PA 19454 (US)
  • GROSS, Paul
    Stockton, CA 95211 (US)
  • BRENDEL, Klaus
    Tucson, AZ 85715 (US)
  • PIAZZA, Gary
    Doylestown, PA 18901 (US)
  • PAMUKCU, Rifat
    Spring House, PA 19477 (US)

(74) Representative: Baverstock, Michael George Douglas et al
BOULT WADE TENNANT,Verulam Gardens70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)

   


(54) N-BENZYL-3-INDENYLACETAMIDES DERIVATIVES FOR TREATING NEOPLASIA